{"altmetric_id":15392324,"counts":{"readers":{"mendeley":15,"citeulike":0,"connotea":0},"total":{"posts_count":22},"news":{"unique_users_count":2,"unique_users":["medicalxpress","eurekalert"],"posts_count":3},"blogs":{"unique_users_count":1,"unique_users":[58079],"posts_count":1},"twitter":{"unique_users_count":11,"unique_users":["HGTJournal","drkamzaki","floszcrxl","Biosurgerysven","lhonuk","MVEG001","TomSilver39","BIOTECH888","Prof_Dollar","YoungChris27040","virus_genome"],"posts_count":18}},"selected_quotes":["AAV vectors containing novel intron enhance transgene expression 40-100x (Free until Jan. 31)","New system for therapeutic gene delivery increases transgene expression up to 100-fold","5\u2032 Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from rAAV Vectors (Free until Feb. 28)"],"citation":{"abstract":"We previously developed a mini-intronic plasmid (MIP) expression system in which the essential bacterial elements for plasmid replication and selection are placed within an engineered intron contained within a universal 5'UTR non-coding exon. Like minicircle DNA plasmids (devoid of bacterial backbone sequences), MIP plasmids overcome transcriptional silencing of the transgene. However, in addition MIP plasmids increase transgene expression by 2 and often >10 times higher than minicircle vectors in vivo and in vitro. Based on these findings, we examined the effects of the MIP intronic sequences in a recombinant AAV (adeno-associated virus) vector system. Recombinant AAV vectors containing an intron with a bacterial replication origin and bacterial selectable marker increased transgene expression by 40 to 100 times in vivo when compared with conventional AAV vectors. Therefore, inclusion of this non-coding exon\/intron sequence upstream of the coding region can substantially enhance AAV-mediated gene expression in vivo.","altmetric_jid":"4f6fa4ec3cf058f610002a0c","authors":["Dr. Jiamiao  Lu","Dr. James  A Williams ","Mr. James  Luke","Ms. Feijie  Zhang","Dr. Kirk Chu","Dr. Mark A Kay","LuJiamiao","WilliamsJames A.","LukeJeremy","ZhangFeijie","ChuKirk","KayMark A.","Lu, Jiamiao","Williams, James A.","Luke, Jeremy","Zhang, Feijie","Chu, Kirk","Kay, Mark A."],"doi":"10.1089\/hum.2016.140","endpage":"134","first_seen_on":"2017-01-11T18:25:32+00:00","funders":["nhlbi"],"issns":["1557-7422","1043-0342"],"issue":"1","journal":"Human Gene Therapy","last_mentioned_on":1503569464,"links":["http:\/\/online.liebertpub.com\/doi\/abs\/10.1089\/hum.2016.140?platform=hootsuite","http:\/\/online.liebertpub.com\/doi\/abs\/10.1089\/hum.2016.140?platform=hootsuite&","http:\/\/online.liebertpub.com\/doi\/pdf\/10.1089\/hum.2016.140","http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/hum.2016.140","http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/hum.2016.140?platform=hootsuite","http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/hum.2016.140?platform=hootsuite&","http:\/\/dx.doi.org\/10.1089\/hum.2016.140","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27903072?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pmid":"27903072","pubdate":"2016-11-30T00:00:00+00:00","publisher":"Mary Ann Liebert Inc","publisher_subjects":[{"name":"Medical Biotechnology","scheme":"era"},{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"125","subjects":["geneticsmedical"],"title":"A 5\u2019non-coding exon containing engineered intron enhances transgene expression from recombinant AAV vectors in vivo","type":"article","volume":"28","mendeley_url":"http:\/\/www.mendeley.com\/research\/5-noncoding-exon-containing-engineered-intron-enhances-transgene-expression-recombinant-aav-vectors"},"altmetric_score":{"score":33.7,"score_history":{"1y":33.7,"6m":0.25,"3m":0.25,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":33.7},"context_for_score":{"all":{"total_number_of_other_articles":8422812,"mean":7.0866213065837,"rank":275617,"this_scored_higher_than_pct":96,"this_scored_higher_than":8147085,"rank_type":"exact","sample_size":8422812,"percentile":96},"similar_age_3m":{"total_number_of_other_articles":277786,"mean":12.439363853339,"rank":16771,"this_scored_higher_than_pct":93,"this_scored_higher_than":261000,"rank_type":"exact","sample_size":277786,"percentile":93},"this_journal":{"total_number_of_other_articles":503,"mean":10.035940239044,"rank":52,"this_scored_higher_than_pct":89,"this_scored_higher_than":451,"rank_type":"exact","sample_size":503,"percentile":89},"similar_age_this_journal_3m":{"total_number_of_other_articles":7,"mean":18.858333333333,"rank":3,"this_scored_higher_than_pct":57,"this_scored_higher_than":4,"rank_type":"exact","sample_size":7,"percentile":57}}},"demographics":{"poster_types":{"member_of_the_public":8,"researcher":1,"practitioner":2},"users":{"twitter":{"cohorts":{"Members of the public":8,"Practitioners (doctors, other healthcare professionals)":2,"Scientists":1}},"mendeley":{"by_status":{"Unspecified":2,"Researcher":6,"Student  > Ph. D. Student":1,"Student  > Postgraduate":1,"Other":2,"Student  > Master":1,"Student  > Bachelor":2},"by_discipline":{"Medicine and Dentistry":2,"Chemistry":1,"Agricultural and Biological Sciences":3,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":5,"Unspecified":2,"Chemical Engineering":1}}},"geo":{"twitter":{"GB":3,"AU":2,"US":2,"NL":1},"mendeley":{"US":1,"GB":1,"ES":1}}},"posts":{"news":[{"title":"New system for therapeutic gene delivery increases transgene expression up to 100-fold","url":"http:\/\/ct.moreover.com\/?a=29394231023&p=1pl&v=1&x=aPvIIRRNV-kEafzgKdVUEQ","license":"public","citation_ids":[15392324],"posted_on":"2017-01-29T02:34:22+00:00","summary":"Advanced engineering of a mini-intronic plasmid (MIP) system designed to carry a therapeutic gene can significantly enhance the expression of the transgene delivered using an adeno-associated viral (AAV) vector.","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"Gene delivery to the lung can treat broad range of diseases within and beyond the lung","url":"http:\/\/ct.moreover.com\/?a=29356342440&p=1pl&v=1&x=m-4RC7_GfvyhzeRvEjA94g","license":"public","citation_ids":[14646962,15392324],"posted_on":"2017-01-25T05:00:00+00:00","summary":"New Rochelle, NY, January 25, 2017--Targeting therapeutic genes to the lungs offers the potential to manage serious lung diseases that do not respond to other forms of treatment and to use the lungs as metabolic factories to produce therapeutic\u2026","author":{"name":"EurekAlert!","url":"http:\/\/www.eurekalert.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/077\/normal\/image.png?1369859505"}},{"title":"New system for therapeutic gene delivery increases transgene expression up to 100-fold","url":"http:\/\/ct.moreover.com\/?a=29380001297&p=1pl&v=1&x=GxwwF0wcOqZ-5SXeSZR1VQ","license":"public","citation_ids":[15392324],"posted_on":"2017-01-27T05:00:00+00:00","summary":"New Rochelle, NY, Jan. 27, 2017 -- Advanced engineering of a mini-intronic plasmid (MIP) system designed to carry a therapeutic gene can significantly enhance the expression of the transgene delivered using an adeno-associated viral (AAV) vector.","author":{"name":"EurekAlert!","url":"http:\/\/www.eurekalert.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/077\/normal\/image.png?1369859505"}}],"twitter":[{"url":"http:\/\/twitter.com\/HGTJournal\/statuses\/819248839836180480","license":"gnip","citation_ids":[15392324],"posted_on":"2017-01-11T18:25:18+00:00","author":{"name":"Human Gene Therapy","image":"https:\/\/pbs.twimg.com\/profile_images\/704367602332786688\/MSMDx6Wu_normal.jpg","id_on_source":"HGTJournal","tweeter_id":"704366654306820096","geo":{"lt":null,"ln":null},"followers":633},"tweet_id":"819248839836180480"},{"url":"http:\/\/twitter.com\/drkamzaki\/statuses\/819291125471182848","license":"gnip","rt":["HGTJournal"],"citation_ids":[15392324],"posted_on":"2017-01-11T21:13:20+00:00","author":{"name":"Kam Zaki","image":"https:\/\/pbs.twimg.com\/profile_images\/792344762175070208\/VLydOW8o_normal.jpg","description":"Medical Oncologist","id_on_source":"drkamzaki","tweeter_id":"792341456837042180","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":70},"tweet_id":"819291125471182848"},{"url":"http:\/\/twitter.com\/HGTJournal\/statuses\/820685832617152513","license":"gnip","citation_ids":[15392324],"posted_on":"2017-01-15T17:35:24+00:00","author":{"name":"Human Gene Therapy","image":"https:\/\/pbs.twimg.com\/profile_images\/704367602332786688\/MSMDx6Wu_normal.jpg","id_on_source":"HGTJournal","tweeter_id":"704366654306820096","geo":{"lt":null,"ln":null},"followers":633},"tweet_id":"820685832617152513"},{"url":"http:\/\/twitter.com\/HGTJournal\/statuses\/823214978123657217","license":"gnip","citation_ids":[15392324],"posted_on":"2017-01-22T17:05:20+00:00","author":{"name":"Human Gene Therapy","image":"https:\/\/pbs.twimg.com\/profile_images\/704367602332786688\/MSMDx6Wu_normal.jpg","id_on_source":"HGTJournal","tweeter_id":"704366654306820096","geo":{"lt":null,"ln":null},"followers":633},"tweet_id":"823214978123657217"},{"url":"http:\/\/twitter.com\/floszcrxl\/statuses\/823637553807032321","license":"gnip","citation_ids":[15392324],"posted_on":"2017-01-23T21:04:29+00:00","author":{"name":"flosz","image":"https:\/\/pbs.twimg.com\/profile_images\/731594030962868224\/fPtH-Z9t_normal.jpg","id_on_source":"floszcrxl","tweeter_id":"142384766","geo":{"lt":null,"ln":null},"followers":386},"tweet_id":"823637553807032321"},{"url":"http:\/\/twitter.com\/HGTJournal\/statuses\/823924677185851393","license":"gnip","citation_ids":[15392324],"posted_on":"2017-01-24T16:05:25+00:00","author":{"name":"Human Gene Therapy","image":"https:\/\/pbs.twimg.com\/profile_images\/704367602332786688\/MSMDx6Wu_normal.jpg","id_on_source":"HGTJournal","tweeter_id":"704366654306820096","geo":{"lt":null,"ln":null},"followers":633},"tweet_id":"823924677185851393"},{"url":"http:\/\/twitter.com\/drkamzaki\/statuses\/823931091673354240","license":"gnip","rt":["HGTJournal"],"citation_ids":[15392324],"posted_on":"2017-01-24T16:30:54+00:00","author":{"name":"Kam Zaki","image":"https:\/\/pbs.twimg.com\/profile_images\/792344762175070208\/VLydOW8o_normal.jpg","description":"Medical Oncologist","id_on_source":"drkamzaki","tweeter_id":"792341456837042180","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":70},"tweet_id":"823931091673354240"},{"url":"http:\/\/twitter.com\/Biosurgerysven\/statuses\/825280899214409728","license":"gnip","rt":["HGTJournal"],"citation_ids":[15392324],"posted_on":"2017-01-28T09:54:34+00:00","author":{"name":"Sven Kili","image":"https:\/\/pbs.twimg.com\/profile_images\/497123957871370240\/_vHVlN2K_normal.jpeg","description":"Surgeon experienced in Clinical Development and Medical Affairs for Cell & Gene Therapy. When not trail running do a little traveling too....","id_on_source":"Biosurgerysven","tweeter_id":"315322262","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":436},"tweet_id":"825280899214409728"},{"url":"http:\/\/twitter.com\/drkamzaki\/statuses\/825326212818026496","license":"gnip","rt":["HGTJournal"],"citation_ids":[15392324],"posted_on":"2017-01-28T12:54:37+00:00","author":{"name":"Kam Zaki","image":"https:\/\/pbs.twimg.com\/profile_images\/792344762175070208\/VLydOW8o_normal.jpg","description":"Medical Oncologist","id_on_source":"drkamzaki","tweeter_id":"792341456837042180","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":70},"tweet_id":"825326212818026496"},{"url":"http:\/\/twitter.com\/HGTJournal\/statuses\/825359076821442561","license":"gnip","citation_ids":[15392324],"posted_on":"2017-01-28T15:05:13+00:00","author":{"name":"Human Gene Therapy","image":"https:\/\/pbs.twimg.com\/profile_images\/704367602332786688\/MSMDx6Wu_normal.jpg","id_on_source":"HGTJournal","tweeter_id":"704366654306820096","geo":{"lt":null,"ln":null},"followers":633},"tweet_id":"825359076821442561"},{"url":"http:\/\/twitter.com\/drkamzaki\/statuses\/825361214968623108","license":"gnip","rt":["HGTJournal"],"citation_ids":[15392324],"posted_on":"2017-01-28T15:13:42+00:00","author":{"name":"Kam Zaki","image":"https:\/\/pbs.twimg.com\/profile_images\/792344762175070208\/VLydOW8o_normal.jpg","description":"Medical Oncologist","id_on_source":"drkamzaki","tweeter_id":"792341456837042180","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":70},"tweet_id":"825361214968623108"},{"url":"http:\/\/twitter.com\/lhonuk\/statuses\/825393503794524166","license":"gnip","rt":["HGTJournal"],"citation_ids":[15392324],"posted_on":"2017-01-28T17:22:01+00:00","author":{"name":"LHONUK","image":"https:\/\/pbs.twimg.com\/profile_images\/571710844417740800\/sctcks6N_normal.jpeg","description":"#LHON: Leber Hereditary Optic Neuropathy - rare #mitochondrial disorder causing #blindness.. share info on living with LHON, research & news.","id_on_source":"lhonuk","tweeter_id":"3064903552","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":254},"tweet_id":"825393503794524166"},{"url":"http:\/\/twitter.com\/MVEG001\/statuses\/827603238341877760","license":"gnip","rt":["HGTJournal"],"citation_ids":[15392324],"posted_on":"2017-02-03T19:42:42+00:00","author":{"name":"Dr Marguerite Galea","url":"https:\/\/www.linkedin.com\/in\/margueriteevansgalea\/","image":"https:\/\/pbs.twimg.com\/profile_images\/911240056018427904\/eT_uxYLD_normal.jpg","description":"Scientist, Executive, Mentor, Speaker, Author, PhD | Exec Director @_IMNIS | Cofounder, CEO @WomenSciAUST | Expert Advisor @scigenderequity | VHRW Ambassador","id_on_source":"MVEG001","tweeter_id":"427330274","geo":{"lt":-37.83333,"ln":144.96667,"country":"AU"},"followers":9003},"tweet_id":"827603238341877760"},{"url":"http:\/\/twitter.com\/TomSilver39\/statuses\/834290735490883584","license":"gnip","citation_ids":[15392324],"posted_on":"2017-02-22T06:36:26+00:00","author":{"name":"Tom Silver","image":"https:\/\/pbs.twimg.com\/profile_images\/3483240655\/dbab1242a5e60beadc49929ccfdc47a8_normal.jpeg","description":"Seek to uncover high-potential investment opportunities. Tweets=just opinions,NOT Investment\/Financial advice. MS","id_on_source":"TomSilver39","tweeter_id":"1330741110","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":2860},"tweet_id":"834290735490883584"},{"url":"http:\/\/twitter.com\/BIOTECH888\/statuses\/834293516687777793","license":"gnip","rt":["TomSilver39"],"citation_ids":[15392324],"posted_on":"2017-02-22T06:47:29+00:00","author":{"name":"Biotech-Catalyst","url":"http:\/\/Biotech-Catalyst.com","image":"https:\/\/pbs.twimg.com\/profile_images\/468823822628433922\/46n-IJpr_normal.jpeg","id_on_source":"BIOTECH888","tweeter_id":"561647557","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":115},"tweet_id":"834293516687777793"},{"url":"http:\/\/twitter.com\/Prof_Dollar\/statuses\/834324406210019328","license":"gnip","rt":["TomSilver39"],"citation_ids":[15392324],"posted_on":"2017-02-22T08:50:14+00:00","author":{"name":"Prof. Dollar","image":"https:\/\/pbs.twimg.com\/profile_images\/889189356241657860\/Ena-FOHW_normal.jpg","description":"Long term investor and biotech enthusiast.","id_on_source":"Prof_Dollar","tweeter_id":"3015098824","geo":{"lt":52.5,"ln":5.75,"country":"NL"},"followers":248},"tweet_id":"834324406210019328"},{"url":"http:\/\/twitter.com\/YoungChris27040\/statuses\/834358312795676672","license":"gnip","rt":["TomSilver39"],"citation_ids":[15392324],"posted_on":"2017-02-22T11:04:58+00:00","author":{"name":"Chris Young","url":"https:\/\/m.facebook.com\/home.php?soft=bookmarks","image":"https:\/\/pbs.twimg.com\/profile_images\/832595198987296769\/VjFKip8q_normal.jpg","description":"Advocate #equality #disabilities #health LT #investor \ud83d\udd0eP-value mrkt intel\" #Biotech paradigm-shift research, pre-eminently humane. retweets not endorsements.","id_on_source":"YoungChris27040","tweeter_id":"1415149603","geo":{"lt":-37.83333,"ln":144.96667,"country":"AU"},"followers":1405},"tweet_id":"834358312795676672"},{"url":"http:\/\/twitter.com\/virus_genome\/statuses\/900661730409304065","license":"gnip","citation_ids":[15392324],"posted_on":"2017-08-24T10:11:04+00:00","author":{"name":"virus_genome","image":"https:\/\/pbs.twimg.com\/profile_images\/521180909693706240\/M3tk_fXm_normal.png","id_on_source":"virus_genome","tweeter_id":"544722510","geo":{"lt":null,"ln":null},"followers":55},"tweet_id":"900661730409304065"}],"blogs":[{"title":"New system for therapeutic gene delivery increases transgene expression up to 100-fold","url":"http:\/\/www.nextbigfuture.com\/2017\/01\/new-system-for-therapeutic-gene.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+blogspot%2Fadvancednano+%28nextbigfuture%29","license":"public","citation_ids":[15392324],"posted_on":"2017-01-30T18:30:00+00:00","summary":"Advanced engineering of a mini-intronic plasmid (MIP) system designed to carry a therapeutic gene can significantly enhance the expression of the transgene delivered using an adeno-associated viral (AAV) vector. The ability to increase transgene expression","author":{"name":"Next Big Future","url":"http:\/\/nextbigfuture.com\/","description":"Tracking high impact progress to the technology future, future technology and especially advanced nanotechnology, nuclear and energy technology, quantum computers, life extension, space technology and AI. Proposing and tracking the best societal, business and technical choices to the next big things that will shape our future. Official Lifeboat Foundation news source."}}]}}